{"url_path":"/fda/drug/recalls/D-0699-2026","section_key":"summary","section_title":"DRUG Recall: Blaine Labs Inc — Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL) bottle, long pointy cap, NDC 63347-120-02; (b) 3.0 Fl OZ (85 g) tube, with short twist cap, NDC 63347-120-01; Manufactured By: Blaine Labs, Inc. 11037 Lockport Place, Santa Fe Springs, CA 90670,","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-08","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0699-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Blaine Labs Inc"},"word_count":127,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0699-2026\n\n**Recalling firm:** Blaine Labs Inc\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-08\n**Report date:** 2026-07-08\n\n## Product\nRevitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL) bottle, long pointy cap, NDC 63347-120-02; (b) 3.0 Fl OZ (85 g) tube, with short twist cap, NDC 63347-120-01; Manufactured By: Blaine Labs, Inc. 11037 Lockport Place, Santa Fe Springs, CA 90670,\n\n## Reason\nCGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated\n\n## Affected lots\nLots: (a) 1 oz - BL3435, Exp 11/06/26; BL3525, Exp 08/07/27. (b) 3 oz- Lots # BL3435, 11/06/26 & BL3525, 08/07/27\n\n## Distribution\nNationwide in the USA"}